Logo image of SARO

STANDARDAERO INC (SARO) Stock Fundamental Analysis

USA - NYSE:SARO - US85423L1035 - Common Stock

26.66 USD
-0.07 (-0.26%)
Last: 9/29/2025, 10:48:05 AM
Fundamental Rating

4

Taking everything into account, SARO scores 4 out of 10 in our fundamental rating. SARO was compared to 69 industry peers in the Aerospace & Defense industry. SARO has a medium profitability rating, but doesn't score so well on its financial health evaluation. SARO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SARO had positive earnings in the past year.
In the past year SARO had a positive cash flow from operations.
SARO Yearly Net Income VS EBIT VS OCF VS FCFSARO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of SARO (2.05%) is comparable to the rest of the industry.
SARO has a Return On Equity (5.29%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 6.97%, SARO is in the better half of the industry, outperforming 62.32% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SARO is below the industry average of 8.29%.
The 3 year average ROIC (5.55%) for SARO is below the current ROIC(6.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.05%
ROE 5.29%
ROIC 6.97%
ROA(3y)-0.27%
ROA(5y)N/A
ROE(3y)-1.45%
ROE(5y)N/A
ROIC(3y)5.55%
ROIC(5y)N/A
SARO Yearly ROA, ROE, ROICSARO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

SARO has a Profit Margin (2.37%) which is comparable to the rest of the industry.
SARO has a Operating Margin (8.16%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SARO has grown nicely.
SARO has a worse Gross Margin (14.90%) than 75.36% of its industry peers.
SARO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.16%
PM (TTM) 2.37%
GM 14.9%
OM growth 3Y17.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.43%
GM growth 5YN/A
SARO Yearly Profit, Operating, Gross MarginsSARO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SARO is destroying value.
SARO has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for SARO has been reduced compared to a year ago.
SARO Yearly Shares OutstandingSARO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 100M 200M 300M
SARO Yearly Total Debt VS Total AssetsSARO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B

2.2 Solvency

SARO has an Altman-Z score of 2.42. This is not the best score and indicates that SARO is in the grey zone with still only limited risk for bankruptcy at the moment.
SARO has a worse Altman-Z score (2.42) than 63.77% of its industry peers.
SARO has a Debt/Equity ratio of 0.91. This is a neutral value indicating SARO is somewhat dependend on debt financing.
The Debt to Equity ratio of SARO (0.91) is worse than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 2.42
ROIC/WACC0.66
WACC10.55%
SARO Yearly LT Debt VS Equity VS FCFSARO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SARO has a Current Ratio of 2.15. This indicates that SARO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.15, SARO is in line with its industry, outperforming 47.83% of the companies in the same industry.
A Quick Ratio of 1.49 indicates that SARO should not have too much problems paying its short term obligations.
SARO's Quick ratio of 1.49 is in line compared to the rest of the industry. SARO outperforms 50.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.49
SARO Yearly Current Assets VS Current LiabilitesSARO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1452.33% over the past year.
SARO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.09%.
SARO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.60% yearly.
EPS 1Y (TTM)1452.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%913%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y14.6%
Revenue growth 5YN/A
Sales Q2Q%13.49%

3.2 Future

SARO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.53% yearly.
SARO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.13% yearly.
EPS Next Y177.04%
EPS Next 2Y89.79%
EPS Next 3Y64.53%
EPS Next 5YN/A
Revenue Next Year15.13%
Revenue Next 2Y13.15%
Revenue Next 3Y12.13%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SARO Yearly Revenue VS EstimatesSARO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SARO Yearly EPS VS EstimatesSARO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 35.08 indicates a quite expensive valuation of SARO.
68.12% of the companies in the same industry are more expensive than SARO, based on the Price/Earnings ratio.
SARO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.54.
With a Price/Forward Earnings ratio of 22.21, SARO is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SARO indicates a somewhat cheap valuation: SARO is cheaper than 73.91% of the companies listed in the same industry.
SARO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 35.08
Fwd PE 22.21
SARO Price Earnings VS Forward Price EarningsSARO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

75.36% of the companies in the same industry are more expensive than SARO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.18
SARO Per share dataSARO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

SARO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SARO's earnings are expected to grow with 64.53% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y89.79%
EPS Next 3Y64.53%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SARO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

STANDARDAERO INC

NYSE:SARO (9/29/2025, 10:48:05 AM)

26.66

-0.07 (-0.26%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11
Inst Owners59.57%
Inst Owner Change18.57%
Ins Owners0.45%
Ins Owner Change-23.98%
Market Cap8.92B
Analysts81.33
Price Target36.27 (36.05%)
Short Float %3.67%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.64%
Min EPS beat(2)6.56%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)33.39%
Min EPS beat(4)6.56%
Max EPS beat(4)87.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.64%
Min Revenue beat(2)0.26%
Max Revenue beat(2)5.02%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)5.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.23%
PT rev (3m)2.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.45%
EPS NY rev (1m)0.18%
EPS NY rev (3m)4.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.78%
Valuation
Industry RankSector Rank
PE 35.08
Fwd PE 22.21
P/S 1.59
P/FCF N/A
P/OCF 121.52
P/B 3.55
P/tB N/A
EV/EBITDA 17.18
EPS(TTM)0.76
EY2.85%
EPS(NY)1.2
Fwd EY4.5%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.22
OCFY0.82%
SpS16.8
BVpS7.51
TBVpS-1.2
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.05%
ROE 5.29%
ROCE 8.82%
ROIC 6.97%
ROICexc 7.09%
ROICexgc 16.54%
OM 8.16%
PM (TTM) 2.37%
GM 14.9%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)N/A
ROE(3y)-1.45%
ROE(5y)N/A
ROIC(3y)5.55%
ROIC(5y)N/A
ROICexc(3y)5.66%
ROICexc(5y)N/A
ROICexgc(3y)15.32%
ROICexgc(5y)N/A
ROCE(3y)7.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.43%
GM growth 5YN/A
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA 3.53
Cap/Depr 81.04%
Cap/Sales 2.76%
Interest Coverage 250
Cash Conversion 11.29%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.49
Altman-Z 2.42
F-Score6
WACC10.55%
ROIC/WACC0.66
Cap/Depr(3y)43.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1452.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%913%
EPS Next Y177.04%
EPS Next 2Y89.79%
EPS Next 3Y64.53%
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y14.6%
Revenue growth 5YN/A
Sales Q2Q%13.49%
Revenue Next Year15.13%
Revenue Next 2Y13.15%
Revenue Next 3Y12.13%
Revenue Next 5YN/A
EBIT growth 1Y25.53%
EBIT growth 3Y34.55%
EBIT growth 5YN/A
EBIT Next Year87.66%
EBIT Next 3Y33.2%
EBIT Next 5YN/A
FCF growth 1Y-169.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.43%
OCF growth 3Y-16.42%
OCF growth 5YN/A